FDA Import Refusal 1FX-4006418-1/10003/1 — Okasa Pharma Pvt. Ltd.
The FDA refused shipment 1FX-4006418-1/10003/1 from Okasa Pharma Pvt. Ltd. (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — LEVOCETIRIZINE DIHYDROCHLORIDE. Cited charges: 118,75
Refusal Details
- Date
- Sep 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XCY51 LEVOCETIRIZINE DIHYDROCHLORIDE
- Charges
- 118,75